Review article: Non-steroidal anti-inflammatory drugs and Helicobacter pylori

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 14, Issue 3, 2000, Pages 43-47

  Barr, M ^a   Buckley, M ^a   O'Morain, C ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; STOMACH SECRETION INHIBITOR;

ACID SECRETION; CELL ACTIVITY; CELL FUNCTION; CLINICAL TRIAL; CONFERENCE PAPER; DIGESTIVE SYSTEM INJURY; ENDOSCOPY; ERADICATION THERAPY; GASTROINTESTINAL HEMORRHAGE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER;

EID: 0033791770     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Mechanisms of non-steroidal anti-inflammatory drug induced gastric damage
2. The physiology of gastric acid secretion
3. Non steroidal anti-inflammatory drugs and peptic ulcer disease
4. Effects of H.pylori products and recombinant cytokines on gastrin release from cultured canine G cells
5. The discovery and function of COX2
6. COX 1 expression in human gastric mucosa infected with H.pylori: Constitutive or induced?
7. H.pylori up regulates type 2 cyclo oxycyenane in gastric epithelial cells
8. Infection of H.pylori in gastric adaptation to continued administration of aspirins in humans
9. Influence of H.pylori in gastric mucosal adaptation to paprosun in man
10. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic steroidal anti-inflammatory drug use
11. Do NSAIDS cause dyspepsia? A meta-analysis evaluating alternative definitions
12. Non steroidal anti-inflammatory drug associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationship to gastric histology, H.pylori infection and other risk factors for peptic ulcer disease
13. Dyspepsia in the community is linked to smoking and aspirin use but not H.pylori infection
14. A comparison of omeprazole with ranitidine for ulcers associated with non steroidal anti-inflammatory drugs
15. Primary gastroduodenal prophylaxis with omeprazole for non steroidal anti-inflammatory drugs users
16. Omeprazole compared with misoprostol for ulcers associated with non steroidal anti-inflammatory drugs. Omeprazole versus misoprostol for NSAID induced ulcer management. Study Group
17. Randomised controlled trial of H.pylori eradication in patients on non steroidal anti-inflammatory drugs. HELP NSAIDS Study
18. Role of H.pylori in ulcer healing and recurrence of gastric and duodenal ulcers in long term NSAID users. Response to omeprazole dual therapy
19. Peptic ulcer bleeding in the elderly: The relative roles of H.pylori and non steroidal anti-inflammatory drugs
20. Randomised trial of eradication of H.pylori before non steroidal anti-inflammatory drug therapy to prevent peptic ulcers
21. Does eradicating H.pylori impair healing of non steroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective study
22. The effect of H.pylori infection in NSAID related gastroduodenal damage in the elderly
23. Gastrointestinal toxicity of NSAIDS